曲妥珠单抗
乳腺癌
医学
肿瘤科
后天抵抗
癌症研究
癌症
泛素
内科学
生物
遗传学
基因
作者
Yutian Zou,Anli Yang,Bo Chen,Xinpei Deng,Jindong Xie,Danian Dai,Jinhui Zhang,Hailin Tang,Tao Wu,Zhigang Zhou,Xiaoming Xie,Jin Wang
标识
DOI：10.1016/j.drup.2024.101126
摘要
With the wide application of trastuzumab deruxtecan (T-DXd), the survival of HER2-low breast cancer patients is dramatically improved. However, resistance to T-DXd still exists in a subset of patients, and the molecular mechanism remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Dean
不能玩一下午吗
大力的灵雁
蓝莓橘子酱
宇宙无敌大火龙
Twonej
zhonglv7
热心市民小红花
GingerF
zheei
贪玩的秋柔
2052669099
pluto
sherry
xiao
Tttttttt
pcr163
殷勤的紫槐
渊渟岳峙江海平
皖公网安备34019202002308
